Delivery Order SPE2DB24D2003-SPE2DB25FXHJ1

Award Date 5/2/25
Potential Completion Date 5/23/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,165.05 delivery order contract is for the supply of ENVARSUS XR 1 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 22, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDLE3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,096.90 firm-fixed-price delivery order is for the supply of Envarsus XR 1 mg tablets, a medication used in various therapeutic areas. The contract has an ultimate completion date of December 5, 2024 and was awarded on November 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award, with an ID of SPE2DX15D1053|SPE2DX24F6JPN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,103.64 firm fixed price delivery order is for the supply of ENVARSUS XR 0.75 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp holds an indefinite...
This federal contract award, ID SPE2DB20D3103|SPE2DB25FM0C1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENVARSUS XR 4 MG TABLET 100S. The contract is a Delivery Order with a Firm Fixed Price of $1,671.16 and an ultimate completion date of January 7, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FY4DG, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENVARSUS XR 1 MG TABLET 100S. The contract has a ceiling value of $2,148.10 and is a Firm Fixed Price Delivery Order type contract, without any set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, identified as SPE2DB20D3103|SPE2DB25FM2N8, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a firm fixed price and a ceiling value of $1,288.86, is a delivery order for the supply of Envarsus XR 1 mg tablets. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 8, 2025. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,230.68, is a delivery order for the supply of 4565232056 - ENVARSUS XR 4 MG TABLET 100S. The contract has a firm fixed price pricing type and an ultimate completion date of August 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of ENVARSUS XR 4 MG TABLET 100S to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,845.99 firm fixed price delivery order has an ultimate completion date of October 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of ENVARSUS XR 4 MG TABLET 100S. The $9,102.93 firm fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract, valued at $8,076.65, is for the delivery of Envarsus XR 4 mg tablets over a period ending on July 30, 2024. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB25FXHJ1
    Delivery Order

This federal contract award, with ID SPE2DB24D2003|SPE2DB25FXHJ1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,711.95 delivery order contract is for the supply of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a performance period extending through May 23, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/3/25, 1:05 AM